0.14Open0.14Pre Close0 Volume111 Open Interest47.50Strike Price0.00Turnover23.79%IV6.46%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier15DDays to Expiry0.14Extrinsic Value100Contract SizeAmericanOptions Type-0.0858Delta0.0631Gamma506.30Leverage Ratio-0.0118Theta-0.0017Rho-43.42Eff Leverage0.0163Vega
Molson Coors Beverage Stock Discussion
$EOG Resources(EOG.US)$ $FS KKR Capital(FSK.US)$ $Molson Coors Beverage(TAP.US)$ $CF Industries Holdings(CF.US)$ $The Mosaic(MOS.US)$ $YIELDMAX NVDA OPTION INCOME STRATEGY ETF(NVDY.US)$
$Waters(WAT.US)$ $Molson Coors Beverage(TAP.US)$ $Anheuser-Busch Inbev(BUD.US)$ $Coca-Cola(KO.US)$ $Xylem(XYL.US)$ $ThaiBev(Y92.SG)$ $Lennar Corp(LEN.US)$ $D.R. Horton(DHI.US)$ $PepsiCo(PEP.US)$ $3M(MMM.US)$ $Applied Materials(AMAT.US)$ $Netflix(NFLX.US)$ $Advanced Micro Devices(AMD.US)$ $Lululemon Athletica(LULU.US)$
Morgan Stanley anticipated annual global sales for weight-loss drugs could reach $77 billion by 2030, higher than its previous $54 billion forecast. $Novo-Nordisk A/S(NVO.US)$ and $Eli Lilly and Co(LLY.US)$ will spli...
No comment yet